Literature DB >> 12162711

A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.

Toshihiro Wajima1, Yoshitaka Yano, Takayoshi Oguma.   

Abstract

A new and simple pharmacokinetic model that can explain enterohepatic circulation profiles for both single and repeated dosing was developed, and its applicability and usefulness were assessed by an actual published data set and simulation study. The model is basically a conventional compartment model, and the transfer rate from the bile compartment to the central compartment is assumed to change periodically, with the sine function being used to describe this periodical change. Using this model, the effect of the parameter values on plasma time-course profiles was examined by simulation, and the applicability of the model was tested by curve fitting to obtain the parameter estimates using an actual published data set. These studies confirmed that our model can simulate the periodical increase of the concentration due to re-absorption. By averaging the sine function in the transfer rate from the bile compartment to the central compartment, a smoothed time-course profile in the elimination phase that is independent of the enterohepatic cycle can be obtained. Also, the apparent half-life in the elimination phase can be estimated, whith is useful especially for evaluating drug accumulation during repeated dosing. It was suggested that the present model can be used to evaluate the drug disposition profile with enterohepatic circulation. The effects of sampling points and sampling time on parameter estimation are also discussed.

Mesh:

Year:  2002        PMID: 12162711     DOI: 10.1211/002235702760089045

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.

Authors:  D R H Huntjens; A Strougo; A Chain; A Metcalf; S Summerfield; D J M Spalding; M Danhof; O Della Pasqua
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

2.  A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.

Authors:  Thorsten Lehr; Alexander Staab; Christiane Tillmann; Dirk Trommeshauser; Hans-Guenter Schaefer; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

3.  Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.

Authors:  Tae Hwan Kim; Soyoung Shin; Cornelia B Landersdorfer; Yong Ha Chi; Soo Heui Paik; Jayhyuk Myung; Rajbharan Yadav; Stefan Horkovics-Kovats; Jürgen B Bulitta; Beom Soo Shin
Journal:  AAPS J       Date:  2015-05-20       Impact factor: 4.009

4.  Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats.

Authors:  Young Jin Moon; Kazuko Sagawa; Kosea Frederick; Shuzhong Zhang; Marilyn E Morris
Journal:  AAPS J       Date:  2006-07-07       Impact factor: 4.009

5.  Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the Rat.

Authors:  Theodoros Papathanasiou; Rasmus Vestergaard Juul; Charlotte Gabel-Jensen; Mads Kreilgaard; Trine Meldgaard Lund
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.200

6.  Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.

Authors:  Peter L Bonate; Simon Floret; Craig Bentzen
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

7.  Pharmacokinetics of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Mice: Potential Enterohepatic Circulation and Target-Mediated Disposition.

Authors:  Xiaowen Guan; Marilyn E Morris
Journal:  Pharm Res       Date:  2019-12-10       Impact factor: 4.200

8.  Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adults.

Authors:  M R Sampson; T P Dumitrescu; K L R Brouwer; V D Schmith
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.